David Gow, right, with Houston Astros president Reid Ryan. Photo by Michele Lee Sparks/Archer Sparks

Last week, the son of a good friend came up to our office. It had been a couple of years since I had seen him, so I still envisioned that he would be an 18-year-old high-school kid. But, when he walked in the room, I did a double-take, as he was now a mature young man. The kid had grown up, and he was standing before me ready to talk business.

In some ways, the story illustrates Gow Media. Sometimes I come across people who will ask me: "How is 1560-The-Game doing?"

We are not that young kid anymore. We have matured from a sports radio venture to a multi-platform media company. And we, too, stand before you ready to talk business.

Here's the story of that grown-up company, with the following highlights:

  • ESPN 97.5 FM: Dominant sports ratings.
  • CultureMap: A large wave of growth.
  • SportsMap: New content and record traffic.
  • InnovationMap: A banner start.
  • SB Nation Radio: Elimination of a competitor.
  • The Team: New faces in leadership roles.

ESPN 97.5 FM

A year ago, we secured the No. 1 sports ratings position. This past quarter, we dominated. In the latest Nielsen book, we have the top four sports shows in the city, and five of the top six. The top four: (No. 1) John and Lance; (No. 2) The Blitz; (No. 3) The Usual Suspects; and (No. 4) The Charlie Pallilo Show. In morning and afternoon drive times, our ratings share was higher than our two competitors combined. And more good news: this quarter the Houston Press announced "The Best Radio Station" in Houston. The winner: ESPN 97.5FM.

CultureMap

Last week, more than 1,000 people in Houston turned out for our Tastemakers event, which sold out for the second year in a row. It is an amazing sight to see hundreds of folks line up early at the door. The turnout embodied the growth of CultureMap, where online traffic is soaring. Our Houston editorial team of Steven Devadanam, Eric Sandler, Ken Hoffman and others is on a roll. For that matter, the same is true of our teams statewide. We are experiencing double-digit growth year-over-year, yielding a very large and loyal following.

SportsMap

Our deep pool of sports experts has led to record traffic levels. One fun feature: We get to try new combinations such as videos featuring Raheel with AJ and Granato; Lance paired with AJ; Faour and Pallilo. Other must-see videos include Charlie Pallilo and Joel Blank (aka "one-take-Jake"). And we continue to get great written contributions from Barry Laminack, Joshua Jordan, Jermaine Every, Cody Stoots, Jerry Bo and, of course, SportsMap editor Fred Faour.

InnovationMap

Due to the collective efforts of many, Houston is experiencing a great wave of innovation. And now the city has a media outlet to tell the stories. Launched late last year, and backed by blue-chip sponsors, InnovationMap is off to a great start.

When we were planning the site, we were continually asked: who would be the editor? We found a good answer: Natalie Harms, whose fingerprints are all over the site. Last week Natalie was honored by AAF Houston, given the "Rising Star" award.

SB Nation Radio

In this business where we provide sports shows and updates for other stations across the country, we have faced a very competitive landscape the past four years. Finally, in January one of our competitors, NBC Sports Radio, withdrew from the market — enabling new growth and increasing our reach. Our SB Nation Radio Network is now heard on 600 radio stations across the country.

The Team

This has been an exciting season of growth for our people also.In the past quarter, we promoted Josh Jordan to assistant editor of SportsMap; Tyler Scott became assistant programming director. And, most notably, we tapped AJ Hoffman to become program director for 97.5 FM.

Most everyone knows Fred and AJ as leading show hosts, but they are proving to be far more. As Editor of SportsMap for the past 18 months, Fred has been a catalyst for our growth and success online. With AJ, we are tapping into his natural programming instincts and leadership. I have enjoyed watching their talents extend beyond the show and into management.

Another double-take

Let's give sage Ken Hoffman the last word. Some may recall that Ken was with us for a short while in the early 1560-The-Game days. Two years ago, he returned to write for CultureMap — so he has some perspective, having seen both our youth and maturity.

The other day, he wandered into my office. Looking at Gow Media, it appears Ken had done a double-take. He declared: "I have something to tell you. You have the best group of people and talent now. You really do. This is different than before. You are a real grown-up company now."

------

David Gow is CEO of Gow Media, which owns ESPN 97.5 FM, CultureMap, SportsMap, InnovationMap, and SB Nation Radio. He is also host of The Boss and The Gloss on SB Nation Radio.

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”